ESTIMATION OF POTENTIAL DOUBLING TIME (TP OT) IN-VIVO, BY FLOW-CYTOMETRY - PRACTICAL PROBLEMS AND POSSIBLE SOLUTIONS

Citation
Mc. Gorisse et al., ESTIMATION OF POTENTIAL DOUBLING TIME (TP OT) IN-VIVO, BY FLOW-CYTOMETRY - PRACTICAL PROBLEMS AND POSSIBLE SOLUTIONS, Bulletin du cancer, 83(10), 1996, pp. 825-834
Citations number
29
Categorie Soggetti
Oncology
Journal title
ISSN journal
00074551
Volume
83
Issue
10
Year of publication
1996
Pages
825 - 834
Database
ISI
SICI code
0007-4551(1996)83:10<825:EOPDT(>2.0.ZU;2-U
Abstract
Kinetic parameters of tumour growth yield predictive values and allow an optimisation of the treatment schedule, especially for fractionatio n in radiotherapy. Among those parameters, the labelling index (LI) an d the potential doubling lime (Tpot) may be measured by flow cytometry , a semi-quantitative analysis, after in vivo administration bf iodode oxyuridine (IdUrd) to humans. This Begg's recommended methodology need s the selection of thresholds and gates whose boundaries are arbitrary . They can be positioned on a more objective basis using a negative co ntrol (aspecific fixation). Moreover a previous identification of the different cell populations of the tumour samples according to the meth od of Vindelov allows a better determination of these cell populations processing IdUrd-DNA staining. This procedure was used with 11 tumour biopsies including mainly head and neck cancers. This method displaye d results similar to the literature concerning LI and Tpot determinati ons as well as shortened Tpot when the patients recurred. One sample h as no labelling at all. A small function, likewise up to 10% of cells exhibiting an S DNA content were not labelled by IdUrd. These cells le ave the S phase or progress too slowly in order to display IdUrd uptak e. Intra-tumoral hypoxia is a possible explanation of these findings. DNA ploidy and the percentage of cells in S phase could be worth while to precise the relationship between DNA index and tumour kinetic. The measurement of Tpot could also be used in other cancers and for optim isation of dose of chemotherapy.